Carregando...
Trials and Tribulations of Interrogating Biomarkers to Define Efficacy of Cancer Risk Reductive Interventions
The challenges of clinical screening of cancer risk reductive interventions (“chemopreventive”) have slowed progress in deployment of therapeutics to reverse or delay the carcinogenesis process. The preoperative or window of opportunity design clinical trial design enrolls subjects rapidly, has shor...
Na minha lista:
Principais autores: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139927/ https://ncbi.nlm.nih.gov/pubmed/23333813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-12-0499 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|